Collateral for a security interest recorded Jul 14, 2023 (Sagard Healthcare Partners (Delaware) LP).
Term ends Aug 14, 2038 · High confidence
20-year base term ends Aug 14, 2038
Held by Altathera Pharmaceuticals LLC
Filed Jul 13, 2020 as application 16/946,941 · Granted May 31, 2022
Base term plus 74 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
2018
2038
Clock starts
Aug 14, 2018
Aug 14, 2018
Term ends
Aug 14, 2038
Aug 14, 2038
Granted
May 31, 2022
May 31, 2022
base term
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
74
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 10,512,620.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
32
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 74 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Aug 14, 2018, when application 16/103,815, the earliest non-provisional in its chain, was filed (this one was filed Jul 13, 2020) | Aug 14, 2038 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +74 days, USPTO patent term adjustment record | Oct 27, 2038 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,512,620) | capped to Aug 14, 2038 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Aug 14, 2038 | High confidence |
This family
| US 10,512,620 | In force Aug 2038 | Aug 2038 |
| US 11,696,902 | In force Aug 2038 | Aug 2038 |
| US 12,390,431 | In force Aug 2038 | Aug 2038 |
| Application 16/849,099 | Abandoned not computed | not computed |
| Application 16/863,567 | Abandoned not computed | not computed |
| US 11,344,518 | this patent Aug 2038 | Aug 2038 |
| Application 17/306,490 | Pending not computed | not computed |
| US 11,610,660 | In force Dec 2041 | Dec 2041 |
8 of 32 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Feb 26, 2021 Reel 55427, frame 934 | Altathera Pharmaceuticals LLC | Sagard Healthcare Royalty Partners, LP | Security Interest |
| Mar 29, 2021 Reel 55820, frame 938 | Somberg, John Charin; Kashfian, Brandon Ira; Molnar, Janos | Altathera Pharmaceuticals LLC | Assignment of Assignor's Interest |
| Jul 14, 2023 Reel 64275, frame 433 | Sagard Healthcare Royalty Partners, LP | Sagard Healthcare Partners (Delaware) LP | Assignment of Security Interest in Patent Collateral |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Aug 2038
Term ends Aug 14, 2038. Maintenance fees still fall due before then
Note
The 74 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 10,512,620.
Citations
10
later US patents cite this one
That is top 25% of utility patents granted in 2022 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.